Invivyd, Inc. - IVVD
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Rajeev Shah | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 7.0% | 21,342,442 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.0% | 43,931 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.0% | 43,931 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.0% | 43,931 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 6.0% | 16,653,036 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 6.0% | 16,653,036 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 6.0% | 16,653,036 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 4.9% | 13,619,218 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 4.9% | 13,619,218 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 3.6% | 9,954,397 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 3.6% | 9,954,397 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.6% | 1,563,852 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.6% | 1,563,852 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 8.3% | 23,573,615 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.0% | 25,525,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.0% | 25,525,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.0% | 25,525,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 28,857,208 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 28,857,208 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 28,857,208 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 28,857,208 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Maverick Capital, Ltd. | 6.7% | 18,970,913 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Maverick Capital Management, LLC | 6.7% | 18,970,913 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Lee S. Ainslie III | 6.7% | 18,970,913 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity Fund III, L.P. | 0.6% | 1,680,160 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity GP III, LLC | 0.6% | 1,680,160 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus PE GP III, LLC | 0.6% | 1,680,160 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 2.2% | 6,028,567 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 2.2% | 6,028,567 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 2.2% | 6,028,567 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 2.8% | 7,708,727 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 2.8% | 7,708,727 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Guy Levy | 2.8% | 7,708,727 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.